Characterization of Human CD8+ T Cells Reactive with Mycobacterium tuberculosis–infected Antigen-presenting Cells
暂无分享,去创建一个
[1] B. Walker,et al. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. , 1997, Journal of immunology.
[2] H. Vordermeier,et al. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. , 1997, Journal of immunology.
[3] A. Sette,et al. Differential effects of cytolytic T cell subsets on intracellular infection. , 1997, Science.
[4] I. Orme,et al. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms , 1997, Infection and immunity.
[5] A. Krensky,et al. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. , 1997, Journal of immunology.
[6] G. Kaplan,et al. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice , 1997, Infection and immunity.
[7] S. Porcelli,et al. CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. , 1996, Journal of immunology.
[8] Donna L. Montgomery,et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine , 1996, Nature Medicine.
[9] M. Colston,et al. Vaccination against tuberculosis by DNA injection , 1996, Nature Medicine.
[10] J. Shabanowitz,et al. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. , 1996, Immunity.
[11] M. Bevan,et al. Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. , 1996, Immunity.
[12] J. Banchereau,et al. Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen. , 1995, Journal of immunology.
[13] R. Germain,et al. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis , 1995, The Journal of experimental medicine.
[14] C. Lowenstein,et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.
[15] S. Porcelli,et al. Recognition of a lipid antigen by GDI-restricted αβ+ T cells , 1994, Nature.
[16] D. Lowrie,et al. Protection against tuberculosis by passive transfer with T-cell clones recognizing mycobacterial heat-shock protein 65. , 1994, Immunology.
[17] G. Kaplan,et al. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin , 1994, The Journal of experimental medicine.
[18] I. Orme,et al. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. , 1994, Journal of immunology.
[19] R. Steinman,et al. Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.
[20] B. Bloom,et al. Evidence for a superantigen in human tuberculosis. , 1994, Immunity.
[21] S. Porcelli,et al. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. , 1994, Nature.
[22] S. Kaufmann,et al. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. , 1994, Immunobiology.
[23] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[24] K. Rock,et al. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Pfeifer,et al. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells , 1993, Nature.
[26] J. Flynn,et al. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] S. Porcelli,et al. CDlb restricts the response of human CD4−8−T lymphocytes to a microbial antigen , 1992, Nature.
[28] E. Pamer,et al. H-2M3 presents a listeria monocytogenes peptide to cytotoxic T lymphocytes , 1992, Cell.
[29] P. A. Biro,et al. Evidence for the expression of non-HLA-A,-B,-C class I genes in the human fetal liver. , 1992, Journal of immunology.
[30] I. Orme. Processing and presentation of mycobacterial antigens: implications for the development of a new improved vaccine for tuberculosis control. , 1991, Tubercle.
[31] A. Kochi,et al. The global tuberculosis situation and the new control strategy of the World Health Organization. , 1991, Tubercle.
[32] H. Orr,et al. HLA non-A,B,C class I genes: Their structure and expression , 1990, Immunologic research.
[33] J. D. de Vries,et al. Antigen recognition by MHC-incompatible cells of a human mismatched chimera , 1988, The Journal of experimental medicine.